Draft for the Drugs and Cosmetics (Amendment)
Bill, 2015 to amend the Drugs and Cosmetics Act, 1940 for upgradation and
introduction of provisions for clinical trials and regulation of medical
devices has been released by the Union Health Ministry.
The bill is set to be proposed in the Budget Session of Parliament by the Department of Health and Family Welfare, which is expected to commence in the last week of February. The Bill is currently placed in public domain to elicit comments and views of the stakeholders including the general public, which can be forwarded to Dr Shailendra Kumar, Director (Drugs), Department of Health and Family Welfare, latest by January 12, 2015.
The Bill proposes to expand the scope of the Act that was introduced in the 1940's to cover new areas and will "regulate the import, manufacture, distribution and sale of drugs, cosmetics, medical devices and conduct of clinical trials and for matters connected therewith or incidental thereto."
The Bill also proposes another major amendment in the medical devices sector, which states, "The Central Government shall, by notification, constitute a Board to be called the Medical Devices Technical Advisory Board to advise the Central Government and State Governments on technical matters pertaining to medical devices, arising out of administration of this Act and to carry out other functions assigned to it by or under this Act".
The Bill also proposes to insert a separate Chapter on medical device, Chapter IIA, on import, manufacture, sale and distribution of notified category of medical device. As per this proposed chapter, "The classification, standards, manufacturing, testing, distribution, labeling, packaging, essential requirements for quality, safety and performance, adverse events, post marketing surveillance, conformity assessment bodies, exemptions, procedure to regulate notified category of medical device, manner and conditions of license shall be such as may be prescribed."